Chief of Department of Surgery
"Fundación Jimenez Díaz" University Hospital. Universidad Autonoma de Madrid
Universidad Autonoma de Madrid
Surgeon with a strong clinical activity based in technology transfer from de bench to de bedside. Currently Professor of Surgery and Chief of Surgery Department at “Fundación Jiménez Díaz” University Hospital (Universidad Autonoma de Madrid, Spain).
As Colorectal Surgeon, I have more than 30 years of experience both in the clinical setting as well as in research (more than 7000 surgical procedure with special focus in Minimal Invasive Surgery by lap). World pioneer in the use of adult mesenchymal stem cells derived from adipose tissue (ASC) in human cell therapy. From 2002, we led a clinical trial process about the use of ASC for the treatment of Crohn´s disease including Phase III clinical trials. These works have led to the introduction in the European market of the first cell therapy drug approved by the EMA for the treatment of fistulas of patients with Crohn's disease (Cx601 / Darvadstrocel / Alofisel), of which he is an inventor with an institutional patent (UAM).
As relevant events can be noted as follow: five international patents in the field of Regenerative Medicine, two cells medicines developed and two companies created based to this scientific activity.
For the last 18 years, my Research Team has been also investigating, in collaboration with other international research groups, in analyzing the transforming ability of Circulating Nucleic Acids in Plasma/Serum (CNAPS/Liquid biopsy) from patients bearing colorectal cancer. This was previously demonstrating in vitro and in animal models, suggesting an infectious origin of cancer, and was tentatively named as the Genometastasis Theory (original theory).
Disclosure information not submitted.
Monday, June 3, 2024
1:51 PM – 1:56 PM ET, USA